Abstract
The growth inhibitory effects of interferons, IFN-alpha and IFN-gamma on human lung cancer cell lines were studied using both a tetrazolium (MTT) colorimetric assay and direct cell counting. Significant discrepancies between the two assays were observed, the MTT assay consistently underestimating the growth inhibitory effects of the IFNs. There was no direct chemical effect of the IFNs on the tetrazolium reduction process. IFN treated cells showed increased cell size compared with control cells, although there was little or no change in cell cycle distribution. Mitochondrial activity was 30-50% greater in IFN-gamma treated cells (COR-L23) than the controls. Reduced formazan production per cell was observed in medium which had supported cell growth for several days. Differential 'medium conditioning' led to a difference in formazan production per cell between IFN and control cells and this was the major basis of the observed discrepancy. This discrepancy was not due to the differences in the glucose concentrations between these media. However, differences in pH between the media proved to be the major contributory factor of the discrepancy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jabbar, S., Twentyman, P. & Watson, J. The MTT assay underestimates the growth inhibitory effects of interferons. Br J Cancer 60, 523–528 (1989). https://doi.org/10.1038/bjc.1989.306
Issue Date:
DOI: https://doi.org/10.1038/bjc.1989.306
This article is cited by
-
Systematic and mechanistic analysis of AuNP-induced nanotoxicity for risk assessment of nanomedicine
Nano Convergence (2022)
-
Addressing artifacts of colorimetric anticancer assays for plant-based drug development
Medical Oncology (2022)
-
Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group
Cancer Chemotherapy and Pharmacology (2018)
-
In vitro and in vivo toxicity assessment of nanoparticles
International Nano Letters (2017)
-
Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays
BMC Research Notes (2015)